Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 15, 2017

Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood

  • Ilaria Vicenti EMAIL logo , Genny Meini , Francesco Saladini , Alessia Giannini , Adele Boccuto , Elisabetta Schiaroli and Maurizio Zazzi
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Massanella M, Richman DD. Measuring the latent reservoir in vivo. J Clin Invest 2016;126:464–72.10.1172/JCI80567Search in Google Scholar PubMed PubMed Central

2. Kiselinova M, De Spiegelaere W, Buzon MJ, Malatinkova E, Lichterfeld M, Vandekerckhove L. Integrated and total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathog 2016;12:e1005472.10.1371/journal.ppat.1005472Search in Google Scholar PubMed PubMed Central

3. Tsiara CG, Nikolopoulos GK, Bagos PG, Goujard C, Katzenstein TL, Minga AK, et al. Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis. AIDS Res Hum Retroviruses 2012;28:366–73.10.1089/aid.2011.0032Search in Google Scholar PubMed

4. Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, et al. HIV-1 DNA predicts disease progression and post-treatment virological control. Elife 2014;3:e03821.10.7554/eLife.03821Search in Google Scholar PubMed PubMed Central

5. Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Duvivier C, Haim-Boukobza S, et al. Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. J Infect Dis 2011;204:1211–6.10.1093/infdis/jir518Search in Google Scholar PubMed

6. Amu S, Lantto Graham R, Bekele Y, Nasi A, Bengtsson C, Rethi B, et al. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection. Medicine 2016;95:e3738.10.1097/MD.0000000000003738Search in Google Scholar PubMed PubMed Central

7. Viard JP, Burgard M, Hubert JB, Aaron L, Rabian C, Pertuiset N, et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 2004;18:45–9.10.1097/00002030-200401020-00005Search in Google Scholar PubMed

8. Busby E, Whale AS, Ferns RB, Grant PR, Morley G, Campbell J, et al. Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR. Sci Rep 2017;7:1209.10.1038/s41598-017-01221-5Search in Google Scholar PubMed PubMed Central

9. Symons J, Chopra A, Malantinkova E, De Spiegelaere W, Leary S, Cooper D, et al. HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retrovirology 2017;14:2.10.1186/s12977-016-0325-2Search in Google Scholar PubMed PubMed Central

10. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One 2013;8:e55943.10.1371/journal.pone.0055943Search in Google Scholar PubMed PubMed Central


Supplemental Material:

This article offers supplementary material (https://doi.org/10.1515/cclm-2017-0587).


Received: 2017-7-5
Accepted: 2017-8-9
Published Online: 2017-9-15
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 23.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2017-0587/html
Scroll to top button